
Prince Akwasi Mensah
Examiner (ID: 16550, Phone: (571)270-7183 , Office: P/2474 )
| Most Active Art Unit | 2474 |
| Art Unit(s) | 2416, 2474 |
| Total Applications | 590 |
| Issued Applications | 431 |
| Pending Applications | 63 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8446373
[patent_doc_number] => 08288427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-16
[patent_title] => 'Methods of treating emesis using growth hormone secretagogues'
[patent_app_type] => utility
[patent_app_number] => 12/082411
[patent_app_country] => US
[patent_app_date] => 2008-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11667
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12082411
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082411 | Methods of treating emesis using growth hormone secretagogues | Apr 9, 2008 | Issued |
Array
(
[id] => 4682883
[patent_doc_number] => 20080249109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'PYRAZINOYLGUANIDINE COMPOUNDS FOR USE AS TASTE MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/061864
[patent_app_country] => US
[patent_app_date] => 2008-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15738
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249109.pdf
[firstpage_image] =>[orig_patent_app_number] => 12061864
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/061864 | Pyrazinoylguanidine compounds for use as taste modulators | Apr 2, 2008 | Issued |
Array
(
[id] => 5310854
[patent_doc_number] => 20090018135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'Methods of treating bowel disorders'
[patent_app_type] => utility
[patent_app_number] => 12/080086
[patent_app_country] => US
[patent_app_date] => 2008-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17136
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20090018135.pdf
[firstpage_image] =>[orig_patent_app_number] => 12080086
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/080086 | Methods of treating bowel disorders | Mar 30, 2008 | Issued |
Array
(
[id] => 4549175
[patent_doc_number] => 07960429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => 'Kappa-opiate agonists for the treatment of diarrhea-predominant irritable bowel syndrome'
[patent_app_type] => utility
[patent_app_number] => 12/044906
[patent_app_country] => US
[patent_app_date] => 2008-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 14
[patent_no_of_words] => 15160
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/960/07960429.pdf
[firstpage_image] =>[orig_patent_app_number] => 12044906
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/044906 | Kappa-opiate agonists for the treatment of diarrhea-predominant irritable bowel syndrome | Mar 6, 2008 | Issued |
Array
(
[id] => 4853330
[patent_doc_number] => 20080319073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'COLONIC DELIVERY THERAPEUTIC AGENTS FOR INFLAMMATORY BOWEL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/039189
[patent_app_country] => US
[patent_app_date] => 2008-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2796
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0319/20080319073.pdf
[firstpage_image] =>[orig_patent_app_number] => 12039189
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/039189 | COLONIC DELIVERY THERAPEUTIC AGENTS FOR INFLAMMATORY BOWEL DISEASE | Feb 27, 2008 | Abandoned |
Array
(
[id] => 4728222
[patent_doc_number] => 20080207766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING AT LEAST ONE UPPER GASTROINTESTINAL SYMPTOM'
[patent_app_type] => utility
[patent_app_number] => 12/033218
[patent_app_country] => US
[patent_app_date] => 2008-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17661
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207766.pdf
[firstpage_image] =>[orig_patent_app_number] => 12033218
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/033218 | METHODS AND COMPOSITIONS FOR TREATING AT LEAST ONE UPPER GASTROINTESTINAL SYMPTOM | Feb 18, 2008 | Abandoned |
Array
(
[id] => 4846484
[patent_doc_number] => 20080182892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Treatment of interstitial cystitis using (6aR, 10aR)-delta-8-tetrahydrocannabinol-11-oic acids'
[patent_app_type] => utility
[patent_app_number] => 12/070342
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8743
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182892.pdf
[firstpage_image] =>[orig_patent_app_number] => 12070342
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/070342 | Treatment of interstitial cystitis using (6aR, 10aR)-delta-8-tetrahydrocannabinol-11-oic acids | Feb 14, 2008 | Abandoned |
Array
(
[id] => 4860426
[patent_doc_number] => 20080269276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'COMPOSITIONS USEFUL FOR TREATING IRRITABLE BOWEL SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 12/069439
[patent_app_country] => US
[patent_app_date] => 2008-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8546
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269276.pdf
[firstpage_image] =>[orig_patent_app_number] => 12069439
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/069439 | COMPOSITIONS USEFUL FOR TREATING IRRITABLE BOWEL SYNDROME | Feb 7, 2008 | Abandoned |
Array
(
[id] => 7530480
[patent_doc_number] => 07842702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-30
[patent_title] => 'Treatment for irritable bowel syndrome'
[patent_app_type] => utility
[patent_app_number] => 12/027564
[patent_app_country] => US
[patent_app_date] => 2008-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 5893
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842702.pdf
[firstpage_image] =>[orig_patent_app_number] => 12027564
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/027564 | Treatment for irritable bowel syndrome | Feb 6, 2008 | Issued |
Array
(
[id] => 6605302
[patent_doc_number] => 20100063102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'TREATMENT OF FAECAL INCONTINENCE'
[patent_app_type] => utility
[patent_app_number] => 12/448731
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2500
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20100063102.pdf
[firstpage_image] =>[orig_patent_app_number] => 12448731
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/448731 | TREATMENT OF FAECAL INCONTINENCE | Jan 27, 2008 | Abandoned |
Array
(
[id] => 4965864
[patent_doc_number] => 20080108684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-ALFA PRODUCTION INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 11/968343
[patent_app_country] => US
[patent_app_date] => 2008-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4240
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108684.pdf
[firstpage_image] =>[orig_patent_app_number] => 11968343
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/968343 | THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-ALFA PRODUCTION INHIBITOR | Jan 1, 2008 | Abandoned |
Array
(
[id] => 4928013
[patent_doc_number] => 20080167376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Methods and products which utilize N-acyl-L-aspartic acid'
[patent_app_type] => utility
[patent_app_number] => 11/966293
[patent_app_country] => US
[patent_app_date] => 2007-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21040
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167376.pdf
[firstpage_image] =>[orig_patent_app_number] => 11966293
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/966293 | Methods and products which utilize N-acyl-L-aspartic acid | Dec 27, 2007 | Abandoned |
Array
(
[id] => 4880442
[patent_doc_number] => 20080153825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'ALPHA-2B RECEPTOR AGONIST AND 5HT4 SEROTONIN RECEPTOR COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/954502
[patent_app_country] => US
[patent_app_date] => 2007-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3439
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153825.pdf
[firstpage_image] =>[orig_patent_app_number] => 11954502
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/954502 | ALPHA-2B RECEPTOR AGONIST AND 5HT4 SEROTONIN RECEPTOR COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS | Dec 11, 2007 | Abandoned |
Array
(
[id] => 4880497
[patent_doc_number] => 20080153880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'PAN-ALPHA-2 RECEPTOR AGONIST AND ACID REDUCER COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/954464
[patent_app_country] => US
[patent_app_date] => 2007-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3710
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153880.pdf
[firstpage_image] =>[orig_patent_app_number] => 11954464
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/954464 | PAN-ALPHA-2 RECEPTOR AGONIST AND ACID REDUCER COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS | Dec 11, 2007 | Abandoned |
Array
(
[id] => 4880449
[patent_doc_number] => 20080153832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'PAN-ALPHA-2 RECEPTOR AGONIST AND RELAXANT COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/954595
[patent_app_country] => US
[patent_app_date] => 2007-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3906
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153832.pdf
[firstpage_image] =>[orig_patent_app_number] => 11954595
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/954595 | PAN-ALPHA-2 RECEPTOR AGONIST AND RELAXANT COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS | Dec 11, 2007 | Abandoned |
Array
(
[id] => 4880544
[patent_doc_number] => 20080153927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'ALPHA-2B RECEPTOR AGONIST AND RELAXANT COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/954080
[patent_app_country] => US
[patent_app_date] => 2007-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4263
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153927.pdf
[firstpage_image] =>[orig_patent_app_number] => 11954080
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/954080 | ALPHA-2B RECEPTOR AGONIST AND RELAXANT COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS | Dec 10, 2007 | Abandoned |
Array
(
[id] => 4880446
[patent_doc_number] => 20080153829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'PAN-ALPHA-2 RECEPTOR AGONIST AND 5HT4 SEROTONIN RECEPTOR COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/953691
[patent_app_country] => US
[patent_app_date] => 2007-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3074
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153829.pdf
[firstpage_image] =>[orig_patent_app_number] => 11953691
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/953691 | PAN-ALPHA-2 RECEPTOR AGONIST AND 5HT4 SEROTONIN RECEPTOR COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS | Dec 9, 2007 | Abandoned |
Array
(
[id] => 4693145
[patent_doc_number] => 20080085916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'METHODS FOR TREATING LOWER URINARY TRACT DISORDERS USING ALPHA2DELTA SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 11/952422
[patent_app_country] => US
[patent_app_date] => 2007-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 43395
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20080085916.pdf
[firstpage_image] =>[orig_patent_app_number] => 11952422
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/952422 | METHODS FOR TREATING LOWER URINARY TRACT DISORDERS USING ALPHA2DELTA SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS | Dec 6, 2007 | Abandoned |
Array
(
[id] => 4939467
[patent_doc_number] => 20080076786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'USE OF RADICAL-SCAVENGING COMPOUNDS FOR TREATMENT AND PREVENTION OF NO-DEPENDENT MICROCIRCULATION DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/949121
[patent_app_country] => US
[patent_app_date] => 2007-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3207
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076786.pdf
[firstpage_image] =>[orig_patent_app_number] => 11949121
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/949121 | USE OF RADICAL-SCAVENGING COMPOUNDS FOR TREATMENT AND PREVENTION OF NO-DEPENDENT MICROCIRCULATION DISORDERS | Dec 2, 2007 | Abandoned |
Array
(
[id] => 8214371
[patent_doc_number] => 08193200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease'
[patent_app_type] => utility
[patent_app_number] => 11/982817
[patent_app_country] => US
[patent_app_date] => 2007-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20583
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193200.pdf
[firstpage_image] =>[orig_patent_app_number] => 11982817
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/982817 | Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease | Nov 4, 2007 | Issued |